ArticleBlood cancer journal2015
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis.
Abstract readLetter
In one paragraph
Article in Blood cancer journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Expression properties, structural features and functional analysis of CALR E381A in MPN patients.American journal of translational research · 2023Article
- Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis.Leukemia · 2021Article
- LowGenes · 2021Article
- Germline variations atOncotarget · 2017Article
- Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.Oncotarget · 2017Article
- Expression of CALR mutants causes mpl-dependent thrombocytosis in zebrafish.Blood cancer journal · 2016Article
- CALR mutation characterization in myeloproliferative neoplasms.Oncotarget · 2016Article
- Screening PCR Versus Sanger Sequencing: Detection of CALR Mutations in Patients With Thrombocytosis.Annals of laboratory medicine · 2016Article
- Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016Article
- Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs).Stem cell investigation · 2015Review
- Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations inTechnology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
K-H Lim1] Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan [2] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [3] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan [4] Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Y-C Chang1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan.
C Gon-Shen Chen1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan [3] Department of Medicine, Mackay Medical College, New Taipei City, Taiwan [4] Institute of Molecular and Cellular Biology, National Tsing-Hua University, Hsinchu, Taiwan.
H-C Lin1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan.
W-T WangLaboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan.
Y-H Chiang1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan.
H-I ChengDivision of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Hsinchu, Taiwan.
N-W Su1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan [3] Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
J LinDivision of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Y-F Chang1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan [3] Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
M-C Chang1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan [3] Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
R-K Hsieh1] Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [2] Laboratory of Good Clinical Research Center, Department of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City, Taiwan.
Y-Y KuoGraduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
W-C Chou1] Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan [2] Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedCalreticulinFemaleHigh-Throughput Nucleotide SequencingHumansJanus Kinase 2MaleMiddle AgedMutationNucleic Acid DenaturationThrombocythemia, EssentialCalreticulinJAK2 protein, humanJanus Kinase 2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.